A scientific statement regarding pain and treatment considerations in patients with PAD has been published by the AHA.

Intermittent fasting may reduce the risk of blood clots and cardiovascular disease by inhibiting platelet activation.

The 2025 guideline introduces notable updates including refined recommendations for dual antiplatelet therapy, cardiogenic ...

The following is a summary of "Low-dose dobutamine stress myocardial contrast echocardiography for evaluating myocardial ...

Coronary artery calcium tests are one the newer tools doctors can use to predict a person's chances of developing cardiovascular problems.

GE HealthCare has delivered the initial subject doses of Flyrcado (flurpiridaz F 18) injection, for coronary artery disease ...

GE HealthCare (GEHC) has delivered the first patient doses of Flyrcado or flurpiridaz F 18 njection, a first-of-its-kind unit dose positron ...

Patients undergo first doses of GE HealthCare's PET radiotracer Flyrcado (flurpiridaz F 18) injection at early adopter sites ...